The World Health Organization announced on May 7 that the new crown inactivated vaccine developed by the China Pharmaceutical Group Beijing Institute of Biological Products has officially passed the emergency use certification.
Several new crown vaccines that have been certified for emergency use by WHO before, are the new crown vaccine jointly developed by American Pfizer Pharmaceuticals Co., Ltd. and German Biotechnology Company, and the British AstraZeneca Pharmaceutical Co., Ltd. and Oxford University jointly developed The two versions are AstraZeneca vaccine , New crown vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson , and new crown vaccine developed by American Moderna.
The new crown vaccine passed by China National Pharmaceutical Group is the only inactivated vaccine. It has been certified for emergency use after being tested by WHO and confirmed its safety, effectiveness and quality. The vaccine is produced in India Under the collapse, China's Sinopharm vaccine will be provided to more poor countries lacking vaccines, which will help balance the demand for vaccines and make further contributions to the global fight against the new crown epidemic.
Compared with mRNA vaccines, it requires harsh low-temperature cold-chain transportation. The characteristics of China's new crown epidemic storage at 2-8 degrees Celsius make it suitable for areas where resources are scarce. In addition, the small label on the vaccine bottle will change color when the vaccine is heated, allowing health workers to visually determine whether the vaccine is safe and available.
Previously, the United States just threw out the statement of "giving up the new crown vaccine patent", trying to shape the image of a "humanitarian savior" and dig a hole for China and Russia. compliment. However, the WHO emergency use certification has passed, and the Chinese vaccine has gone farther and farther, and has greater influence. In the end, it still makes the United States feel sour.
So why should Germany strongly oppose the US proposal to "give up the new crown vaccine patent", which is so beneficial to the global fight against the epidemic?
Because Pfizer vaccine is a candidate product developed by the proprietary mRNA vaccine platform of German biotechnology company BioNTech, Pfizer provides a series of commercial operations for vaccines including clinical research, development, approval, and production, but because of Pfizer’s reputation Bigger so named after Pfizer.
Biden has one mouth, and the generosity of others is the generosity of others.
The mRNA sequence of the new crown vaccine developed by the American company Moderna belongs to several scientists of Stanford University , and it was published on the open source platform by them long ago.
As for in the United States, Johnson & Johnson in the United States and AstraZeneca in the United Kingdom use the DNA vaccine of the adenovirus vector .
AstraZeneca's vaccine patent is not very easy to use anyway, the United States controls the United Kingdom to live or die?
At present, according to various reports, mRNA vaccines still have significant side effects. Kapila died after being infected in India...
China has started five-line vaccine development since the outbreak last year - live vaccine , recombinant protein vaccine , adenovirus vector vaccine, attenuated influenza virus vector live vaccine, Nucleic acid vaccine , speed up vaccine development in an all-round way, and announce the new coronavirus gene sequence to the world as soon as possible.
Because the inactivated vaccine technology is the most stable and mature, China chooses inactivated vaccines to spread first, but because the whole process of inactivation takes a long time, according to past experience, it takes about 10 years. The new crown inactivated vaccine was developed within a year.
According to relevant experts, inactivated vaccines require manufacturers to have certain protection standards, and the virus strain needs to be cultivated, which is costly.
In the West, such as the United States, the R&D and production are all private companies. Naturally, they chose the method of short time and quick benefit. The mRNA vaccine originally studied for cancer patients, because it does not need to cultivate viruses, the production speed is very fast, so it is naturally listed. is preferred. But it has to be said that because the whole process is too hasty, the safety of mRNA vaccine technology is still in doubt when it is used on a large scale for the first time on healthy humans - at least, it is openly written in Pfizer's contract that "any Side effects, Pfizer is not responsible for", which is meaningful.
The reason why Sinopharm China Bio-New Crown Vaccine can be certified by WHO, in addition to its convenience and widespread use, is naturally its safety that has been repeatedly verified, and its annual production capacity of 3 billion is also a huge advantage. The inclusion of Sinopharm's new crown vaccine into the emergency use list is a manifestation of China's vaccines going to the world and a manifestation of the quality level and comprehensive strength of a country and an enterprise's pharmaceutical vaccine R&D and production. After Sinopharm China Bio's new crown vaccine, Sinovac vaccine will also receive the final evaluation report. (Jinxuan)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-